News
Stories about the companies we track, gathered daily from UK and European tech press and Google News. Headlines link to the original publisher.
- Partnerships & dealsStreetInsider, 7 days agoPrimary Sclerosing Cholangitis Pipeline Update 2026: Clinical Development Status, Collaborations, and Key Companies to Watch | Engitix, GRI Bio, Qing Bile Therapeutics, Sirnaomics, Cascade Pharma
- LeadershipPulse 2.0, 19 days agoEngitix Appoints Former BioNTech Executive Ryan Richardson To Board Of Directors
- LeadershipPMLiVE, 23 Sept 2026Engitix appoints Sonia Quaratino as EVP Chief Medical Officer
- Partnerships & dealsPharmafile, 28 Jul 2026Lonza and Engitix partner to develop next-generation antibody-drug conjugates
- ExpansionGenetic Engineering and Biotechnology News, 22 Jul 2026Engitix Licenses Lonza’s Technology to Advance ADC Therapies
- OtherThe Healthcare Technology Report., 22 Jul 2026Engitix’s Giuseppe Mazza is Looking Beyond the Cell
- ExpansionCHEManager, 22 Jul 2026Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development
- Partnerships & dealsContract Pharma, 21 Jul 2026Lonza, Engitix Ink ADC Licensing Deal
- ExpansionBioPharm International, 21 Jul 2026Lonza, Engitix Ink ADC License Deal for ECM-Targeted Cancer, Fibrosis Therapies
- FundingYahoo Finance, 12 Jun 2026GSK Engitix Liver Fibrosis Pact Adds Early Stage Upside For Valuation
- OtherLongevity.Technology, 10 Jun 2026Can liver fibrosis be undone? Engitix, GSK aim to find out
- Partnerships & dealsPluang, 8 Jun 2026Engitix partners with GSK to develop new treatm...
- Partnerships & dealsthepharmaletter.com, 8 Jun 2026Engitix inks collaboration with GSK for liver fibrosis drugs
- Partnerships & dealsYahoo Finance, 8 Jun 2026Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression
- Otherendpoints.news, 8 Jun 2026GSK inks multi-target liver pact with Engitix; Sangamo considers strategic options
- Partnerships & dealsLatham & Watkins LLP, 8 Jun 2026Latham Advises GSK on Strategic Collaboration With Engitix
- Partnerships & dealsEuropean Biotechnology Magazine, 8 Jun 2026GSK taps Engitix’s platform in liver fibrosis deal worth up to £44.5m upfront
- FundingBeinsure, 2 Feb 2026BioTech Engitix lands €21 mn extension to push ECM cancer therapies
- FundingHealthcare Today, 23 Jan 2026Engitix raises $25 million in Series A funding
- FundingUKTN, 8 Jan 2026Engitix secures £18.6m to advance cancer and fibrosis therapies
- OtherBloomberg.com, 7 Jan 2026Billionaire Hedge Fund Manager Michael Platt Invests in UK Biotech Firm Engitix
